Wart Corn Remover

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by their rough, cauliflower-like surface. Additionally, it is indicated for the removal of plantar warts, which are specifically located on the bottom of the foot and are identified by tenderness and disruption of the footprint pattern.

Limitations of Use: This drug is not indicated for the treatment of warts located in areas other than the common and plantar regions.

Dosage and Administration

Healthcare professionals should apply a layer of ointment using the provided applicator (cotton swab) to sufficiently cover each wart. It is essential to allow the ointment to fully absorb into the skin. If necessary, the treated area may be covered with a bandage to protect it.

This application should be repeated once or twice daily, as needed, until the wart is removed. Treatment may continue for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Application on damaged skin, including areas with cuts, abrasions, eczema, or sunburn, is prohibited due to the potential for exacerbating skin conditions and increasing the risk of systemic absorption.

The product should not be applied to irritated, infected, or reddened skin, as this may lead to further irritation or complications.

Patients with diabetes or poor blood circulation should avoid use, as these conditions may impair healing and increase the risk of adverse effects.

Additionally, the product is contraindicated in pregnant or breastfeeding individuals due to potential risks to the fetus or infant.

Warnings and Precautions

Healthcare professionals are advised to adhere to the following warnings and precautions to ensure the safe use of this product.

It is imperative to keep the product out of reach of children to prevent accidental ingestion or misuse. The liquid formulation is prone to volatilization and crystallization; therefore, it is essential to securely tighten the cap after each use to maintain its integrity. Long-term exposure to air should be avoided during application to preserve the product's efficacy.

This product is intended for external use only. Direct contact with the eyes must be avoided, and it should not be ingested. Children should use this product only under the supervision of an adult to ensure safety.

Application on damaged skin, including cuts, abrasions, eczema, or sunburn, is contraindicated. Additionally, the product should not be applied to irritated, infected, or reddened skin, as this may exacerbate the condition.

Patients with diabetes or those who exhibit poor blood circulation should refrain from using this product due to the increased risk of adverse effects. Furthermore, it is not recommended for use during pregnancy or while breastfeeding, as safety in these populations has not been established.

If discomfort persists for more than 72 hours following application, it is crucial to discontinue use and consult a healthcare provider for further evaluation and management.

Side Effects

Patients should be aware of several important safety considerations regarding the use of this product. It is essential to keep the product out of reach of children to prevent accidental ingestion or misuse. The liquid formulation is prone to volatilization and crystallization; therefore, users should ensure that the cap is tightly secured after each use to maintain product integrity. Long-term exposure to air should be avoided during use to prevent degradation of the product.

This product is intended for external use only. Patients must take care to avoid contact with the eyes and should not swallow the product. It is recommended that children use this product only under the supervision of adults to ensure safe application.

In the event that discomfort persists for more than 72 hours, patients are advised to discontinue use and consult a healthcare professional for further evaluation and guidance.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Corn Remover (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this medication under the supervision of adults to ensure safety and proper administration. It is important to keep the medication out of reach of children to prevent accidental ingestion or misuse.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should be advised to consult their healthcare provider regarding the use of this medication. The potential risks and benefits must be carefully considered in these populations. There is limited data available on the effects of this medication during pregnancy and lactation, and its safety has not been established. Therefore, healthcare professionals should exercise caution and evaluate the necessity of treatment in pregnant or breastfeeding women.

Lactation

Lactating mothers should be aware of the potential implications of using this medication while breastfeeding. There is limited information available regarding the excretion of this drug in human breast milk. Therefore, healthcare professionals should carefully consider the benefits and risks of administering this medication to lactating mothers.

Breastfed infants may be affected by the presence of the drug in breast milk, although specific data on the effects in nursing infants are not provided. It is advisable for healthcare providers to monitor breastfed infants for any adverse effects if the mother is using this medication.

In summary, the decision to use this medication in lactating mothers should involve a thorough assessment of the potential risks to the infant versus the therapeutic benefits to the mother.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information may necessitate individualized assessment and monitoring based on the patient's overall clinical status and renal function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or toxicology experts for guidance on specific management protocols and interventions tailored to the situation.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion or misuse. Patients should be informed that the product should not be applied to damaged skin, including areas with cuts, abrasions, eczema, or sunburn. Additionally, it is important to avoid application on irritated, infected, or reddened skin.

Patients with diabetes or those who have poor blood circulation should be cautioned against using this product without consulting their healthcare provider. Pregnant or breastfeeding patients should also be advised to seek medical guidance before using the product.

Healthcare providers should instruct patients to stop using the product and consult their doctor if discomfort persists for more than 72 hours. Patients should be reminded to wash the affected area before application and may benefit from soaking the wart in warm water for 5 minutes to enhance the treatment's effectiveness. After drying the area thoroughly, patients should use the applicator (such as a cotton swab) to apply a layer of ointment that sufficiently covers each wart.

It is essential to inform patients to allow the ointment to fully absorb and to cover the area with a bandage as needed. This procedure should be repeated once or twice daily as necessary until the wart is removed, for a maximum duration of 12 weeks.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored at a temperature range of 20° to 25°C (68° to 77°F). Care must be taken to protect the product from excessive heat, specifically temperatures exceeding 40°C (104°F). Proper storage conditions are essential to maintain the integrity and efficacy of the product.

Additional Clinical Information

The product is administered topically, with the recommended frequency being once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks. Clinicians should counsel patients to keep the product out of reach of children and to avoid prolonged exposure to air during use.

Patients with diabetes or poor blood circulation, as well as those who are pregnant or breastfeeding, should exercise caution. If discomfort persists for more than 72 hours, patients are advised to discontinue use and consult a healthcare professional.

Drug Information (PDF)

This file contains official product information for Wart Corn Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)